Roche (RHHBY)(RHHBF)(RHHVF) said its experimental eye drug vamikibart helped patients maintain improvements in vision for a full year in two late-stage clinical trials, potentially offering an ...

The thought of receiving an injection in the eye may cause anxiety to many people. Doctors use eye injections to treat certain eye health conditions, such as retinal vein occlusion or diabetic ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...

W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...

SOUTH SAN FRANCISCO, Calif., May 22, 2025--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has ...

If you have wet age-related macular degeneration (wet AMD) or another disease of the retina, your doctor may recommend treatment with an anti-VEGF drug. VEGF, or vascular endothelial growth factor, is ...

Ranibizumab implants approved by FDA for DME offer a more convenient treatment schedule, reducing injection frequency significantly. The phase 3 Pagoda study showed noninferior visual acuity with ...

Age-related macular degeneration (AMD) is an eye condition that can affect central vision, which is the vision used for activities such as reading and recognizing faces. In people with wet AMD, ...